Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by 5aminolevulinic Acid 5ala

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01508741Not ApplicableCompleted

Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood

Showing all 1 trials

Research Network

Common Treatments

  • 5aminolevulinic Acid 5ala1

Active Sponsors

  • University of Hawaii1
  • SBI ALApromo Co., Ltd. - Strategic Business Innovator1

Top Investigators

  • Rosanne C. Harrigan, Ed.D.1

    University of Hawaii at Manoa, John A. Burns School of Medicine, Dept. of Complementary and Alternative Medicine

  • Beatriz L. Rodriguez, M.D.1

    University of Hawaii at Manoa, John A. Burns School of Medicine, Dept. of Complementary and Alternative Medicine and Dept. of Geriatric Medicine

  • Terry Shintani, M.D.1

    University of Hawaii at Manoa, John A. Burns School of Medicine, Dept. of Complementary and Alternative Medicine

Related Conditions

  • Insomnia1
  • Stress1
  • Coping Behavior1
  • Irritability1

Activity Timeline